[News] Biomarker for fibrolamellar hepatocellular carcinoma

22:21 EST 6 Mar 2014 | The Lancet

Findings from a genetic analysis study uncovered a unique mutation that could be implicated in the pathogenesis of fibrolamellar hepatocellular carcinoma (FL-HCC). FL-HCC is a rare disease that afflicts teens and young adults, is refractory to chemo...

Original Article: [News] Biomarker for fibrolamellar hepatocellular carcinoma

NEXT ARTICLE

More From BioPortfolio on "[News] Biomarker for fibrolamellar hepatocellular carcinoma"

Search BioPortfolio:
Loading
Advertisement
Advertisement